186 related articles for article (PubMed ID: 18569448)
1. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice.
Patel GB; Ponce A; Zhou H; Chen W
J Liposome Res; 2008; 18(2):127-43. PubMed ID: 18569448
[TBL] [Abstract][Full Text] [Related]
2. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
3. Safety of intranasally administered archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) vaccine in mice.
Patel GB; Ponce A; Zhou H; Chen W
Int J Toxicol; 2008; 27(4):329-39. PubMed ID: 18821397
[TBL] [Abstract][Full Text] [Related]
4. Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice.
Shahiwala A; Amiji MM
J Drug Target; 2008 May; 16(4):302-10. PubMed ID: 18446609
[TBL] [Abstract][Full Text] [Related]
5. Archaeal lipid mucosal vaccine adjuvant and delivery system.
Patel GB; Chen W
Expert Rev Vaccines; 2010 Apr; 9(4):431-40. PubMed ID: 20370552
[TBL] [Abstract][Full Text] [Related]
6. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
Akache B; Stark FC; Jia Y; Deschatelets L; Dudani R; Harrison BA; Agbayani G; Williams D; Jamshidi MP; Krishnan L; McCluskie MJ
PLoS One; 2018; 13(12):e0208067. PubMed ID: 30513093
[TBL] [Abstract][Full Text] [Related]
7. Safety of archaeosome adjuvants evaluated in a mouse model.
Patel GB; Omri A; Deschatelets L; Sprott GD
J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration.
Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z
Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge.
Patel GB; Zhou H; Ponce A; Harris G; Chen W
PLoS One; 2010 Dec; 5(12):e15574. PubMed ID: 21206916
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
Vadolas J; Davies JK; Wright PJ; Strugnell RA
Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
[TBL] [Abstract][Full Text] [Related]
12. Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.
Ishii M; Kojima N
Glycoconj J; 2010 Jan; 27(1):115-23. PubMed ID: 19816665
[TBL] [Abstract][Full Text] [Related]
13. Surface-linked liposomal antigen induces ige-selective unresponsiveness regardless of the lipid components of liposomes.
Nakano Y; Mori M; Nishinohara S; Takita Y; Naito S; Kato H; Taneichi M; Komuro K; Uchida T
Bioconjug Chem; 2001; 12(3):391-5. PubMed ID: 11353537
[TBL] [Abstract][Full Text] [Related]
14. Archaeosomes as adjuvants for combination vaccines.
Patel GB; Zhou H; KuoLee R; Chen W
J Liposome Res; 2004; 14(3-4):191-202. PubMed ID: 15676126
[TBL] [Abstract][Full Text] [Related]
15. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization.
Liu Q; Zhang C; Zheng X; Shao X; Zhang X; Zhang Q; Jiang X
Vaccine; 2014 May; 32(22):2582-90. PubMed ID: 24681230
[TBL] [Abstract][Full Text] [Related]
17. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
Even MP; Young K; Winter G; Hook S; Engert J
Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
[TBL] [Abstract][Full Text] [Related]
18. Archaeosome immunostimulatory vaccine delivery system.
Patel GB; Chen W
Curr Drug Deliv; 2005 Oct; 2(4):407-21. PubMed ID: 16305444
[TBL] [Abstract][Full Text] [Related]
19. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
Howe SE; Konjufca VH
PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
[TBL] [Abstract][Full Text] [Related]
20. Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization.
Wang HW; Jiang PL; Lin SF; Lin HJ; Ou KL; Deng WP; Lee LW; Huang YY; Liang PH; Liu DZ
Acta Biomater; 2013 Mar; 9(3):5681-8. PubMed ID: 23159567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
